Streetbeat News

Products Services

ALT

Altimmune's stock price declined following the release of disappointing Q4 FY23 earnings and underwhelming lean mass preservation data for pemvidutide.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:07 am

IBIO

iBio, Inc. (IBIO) has announced a collaboration with AstralBio, Inc. to develop novel antibodies for treating obesity and cardiometabolic diseases. This follows iBio's recent $15 million private placement financing aimed at supporting new partnerships like the one with AstralBio.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:06 am

V

Visa (NYSE:V) announced the expansion of its services business with three new AI-powered risk and fraud prevention products within the Visa Protect suite, aimed at reducing fraud in various payment scenarios.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:05 am

ALT

Altimmune released data from a body composition study on Pemvidutide, showing 25.5% of weight loss came from lean mass and 74.5% from adipose tissue. This data highlights Pemvidutide's effectiveness in targeting fat loss while preserving lean mass.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:03 am

ETH-USD

Ethereum co-founder Vitalik Buterin, at the BUIDL Asia conference in Seoul, criticized the current understanding of the Metaverse, describing it as 'poorly defined' and more of a 'brand name than a product'. He emphasized that the Metaverse should not be equated solely with virtual reality but should integrate cryptocurrencies, VR, AI, and more for a truly functional experience. Additionally, Buterin invited Elon Musk to explore desktop Linux as an alternative to Microsoft's OS.

Portfolio Pulse from Mehab Qureshi

March 27, 2024 | 11:00 am

KMB

Kimberly-Clark announces a strategic overhaul aiming for over $3B in gross productivity savings and $500M in working capital savings. The company targets organic net sales growth ahead of market growth and adjusted EPS growth in mid-to-high single digits. Additionally, it commits to a 100% natural forest-free ambition across its product portfolio.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:57 am

ESLT

Elbit Systems has been chosen by a European country to upgrade its 155mm howitzer battalions with advanced Digital Fires capabilities. This will include integrating Elbit's C4ISR Artillery Suite, Torch-X Fires application, and E-LynX Software Defined Radio (SDR) radios.

Portfolio Pulse from Charles Gross

March 27, 2024 | 10:54 am

ANIP

ANI Pharmaceuticals, Inc. (ANIP) has launched Levofloxacin Oral Solution, a generic version of Levaquin. The U.S. market for this product is estimated at $7.1 million annually, based on data from IQVIA/IMS Health.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:51 am

QS

QuantumScape Corporation (NYSE:QS) has started shipping Alpha-2 prototype battery cells to customers, achieving a significant 2024 goal ahead of schedule. These prototypes are crucial for the development of QuantumScape's first commercial product, QSE-5, and feature improvements such as higher energy density compared to previous prototypes.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:47 am

SPIR

Spire Global has entered into an agreement to build and operate satellites for HANCOM InSpace, aiming to expand the capabilities of HANCOM-1 (Sejong-1) and establish Korea's first three-satellite remote sensing image data service constellation.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:46 am